Navigation Links
Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results
Date:2/27/2009

- 16% Growth in Annual Net Sales Driven by Demand for Branded Products

- Adjusted Diluted EPS of $2.40 from Operations, up 25% from 2007

- Provides 2009 Adjusted EPS Guidance Range of $2.59 - $2.67

CHADDS FORD, Pa., Feb. 27 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today reported double-digit percentage growth in net sales and adjusted diluted earnings per share for the fourth quarter and full year ended December 31, 2008.

Net sales for the three months ended December 31, 2008 increased 14% to $347.3 million compared with $304.6 million in the fourth quarter of 2007. Net income for the three months ended December 31, 2008 was $74.9 million compared with $50.6 million in the comparable 2007 period.

Diluted earnings per share for the three months ended December 31, 2008 were $0.64 compared with $0.38 in the comparable 2007 period. As detailed in the Supplemental Financial Information below, adjusted diluted earnings per share for the three months ended December 31, 2008 increased 37% to $0.71 compared with $0.52 in the same period in 2007.

Full-Year Results

Net sales for the year ended December 31, 2008 were $1.261 billion compared with $1.086 billion for the year ended December 31, 2007, an increase of 16%. Net income for the year ended December 31, 2008 was $261.7 million versus $227.4 million in the comparable 2007 period.

Diluted earnings per share for the year ended December 31, 2008 were $2.12 compared with $1.69 in the comparable 2007 period. As detailed in the Supplemental Financial Information below, adjusted diluted earnings per share for the full year 2008 increased 25% to $2.40 compared with $1.92 in 2007.

Selected Product Review

LIDODERM
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
2. Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results and Highlights
3. Arbor Pharmaceuticals Announces the Launch of XYLAREX(TM) - A New Nonantibiotic Product for the Dietary Management of Recurrent Ear Infections in Children
4. Endo Pharmaceuticals Appoints William Montague to Board of Directors
5. Access Pharmaceuticals Closes Acquisition of MacroChem Corp.
6. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results
7. Valeant Pharmaceuticals Reports Fourth Quarter and Full Year Financial Results
8. Transdel Pharmaceuticals, Inc. Featured on National Broadcast Television
9. Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results
10. Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP
11. Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... Pittsburgh, Pa (PRWEB) June 03, 2015 EMBARGOED ... , Lower Birth Weight Associated with Proximity of Mother’s Home ... women living close to a high density of natural gas ... babies with lower birth weights than women living farther from ... School of Public Health analysis of southwestern Pennsylvania birth ...
(Date:6/3/2015)... 03, 2015 Johnson & Johnson and ... million to resolve a Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) ... company allegedly used to market the antipsychotic drug. ... that the Arkansas Attorney General moved to dismiss the ... The Risperdal settlement amounts to just a fraction of ...
(Date:6/3/2015)... Follow us on LinkedIn – ... treatment on account of their better mode of action ... rheumatoid arthritis. The industry is expected to witness a ... drugs to biopharmaceuticals over the coming years. The high ... therapies, and recombinant proteins has attracted industry players to ...
(Date:6/3/2015)... June 03, 2015 Dr. Steven Reisman, a ... Diagnostic Center ( http://www.newyorkcardiac.com ) located in NYC, announced today ... to his practice. In most cases, depending on the level ... day they call, they will be seen by a cardiologist ... as a cardiologist is to ensure that people who have ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 VeoMed ... to expand online and mobile access to premier ... and Maintenance of Certification (MOC) activities. ... VeoMed’s innovative courses to Decker’s extensive lists of ... in purchasing access to VeoMed’s premier online and ...
Breaking Medicine News(10 mins):Health News:Fracking Proximity Associated with Lower Birth Weight 2Health News:Fracking Proximity Associated with Lower Birth Weight 3Health News:Fracking Proximity Associated with Lower Birth Weight 4Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 3Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 4Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:NYC Cardiologist, Dr. Steven Reisman, Announces Same Day and Evening Appointments 2Health News:VeoMed and Decker Intellectual Properties, the Owner of Scientific American Medicine, Announce a Partnership to Expand Access to Premier Online CME Courses 2
... be especially diligent about having routine screening colonoscopies, results ... at Buffalo indicate. , Their findings show that persons ... polyps, known as adenomas, and advanced adenomas than men ... were presented Oct. 19 at a 10:30 a.m. session ...
... Dogs may not only be man,s best friend, they ... children with special needs. According to a new Universit de ... anxiety and enhance the socialization skills of children with Autism ... Psychoneuroendocrinology may be a relatively simple solution to help ...
... is not a foreign sight. But what about a turtle or ... fact, according to Gordon Burghardt, a psychology professor at the University ... monkeys -- need a little play time. "I studied ... never saw anything that I thought was play. Then I had ...
... SEATTLE, Wash.October 18, 2010Researchers at the Allen Institute for ... different activity patterns in the brain in individuals with ... individual differences in the effectiveness and side-effect profiles of ... The study is available in this week,s online early ...
... Oct. 19 (HealthDay News) -- People with depression and ... undergoing surgery, a new study suggests. U.S. researchers ... care units between Oct. 1, 2003 and Sept. 30, ... existing psychiatric condition, including 5,500 (15.5 percent) with depression, ...
... , MONDAY, Oct. 18 (HealthDay News) -- Invasive dental procedures ... heart attack and stroke, researchers say. But the increase ... "I don,t want to downplay this entirely, because we ... just after dental work was done among patients undergoing invasive ...
Cached Medicine News:Health News:Prostate cancer patients are at increased risk of precancerous colon polyps 2Health News:Children's best friend 2Health News:UT professor defines play, discovers even turtles need recess 2Health News:Gene activity in the brain depends on genetic background 2Health News:Depression, Anxiety May Raise Surgery Risks 2Health News:Invasive Dentistry May Raise Short-Term Heart, Stroke Risk 2Health News:Invasive Dentistry May Raise Short-Term Heart, Stroke Risk 3
(Date:6/3/2015)... SEATTLE , June 3, 2015 ... acquire Northeast Pharmaceuticals, Inc., bringing together two pharmacy organizations ... with mental illness. Both companies have strong reputations for ... their customers. Genoa ... the behavioral health community and those affiliated with managing ...
(Date:6/3/2015)... , June 3, 2015 Creekridge Capital, ... of its sales channels by adding two new sales ... as a Regional Sales Manager and Stefanie Stark ... Mr. Puma comes to Creekridge with over 20 ... his role at Creekridge, Mr. Puma will be responsible ...
(Date:6/3/2015)...  Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... with AbbVie (NYSE: ABBV ) to develop and ... ENHANZE ™ platform. Under ... an initial $23 million payment, followed by milestone ... up to nine collaboration targets. These payments are ...
Breaking Medicine Technology:Genoa, a QoL Healthcare Company Acquires Northeast Pharmaceuticals, Inc. 2Creekridge Capital Strengthens Sales Team 2Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 2Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 3
... 3, 2011 Reportlinker.com announces that a new market ... Probiotics and Prebiotics in Clinical Nutrition ... Introduction Overall sales of clinical nutrition ... US and EU as well as rising incidence of ...
... May 3, 2011 Researchers from the University of ... American Roentgen Ray Society 2011 Annual Meeting ... and reduce radiation exposure for breast cancer patients.   ... systems that can show the location as well as ...
Cached Medicine Technology:Reportlinker Adds Probiotics and Prebiotics in Clinical Nutrition 2Reportlinker Adds Probiotics and Prebiotics in Clinical Nutrition 3Reportlinker Adds Probiotics and Prebiotics in Clinical Nutrition 4Study Shows Same Day PET-Guided Biopsy May Expedite Pre-Operative Work-up For Breast Cancer Patients and Reduce Radiation Exposure 2
... on-the-spot reference guide for ... On the wards, in ... or at the bedside, ... access to reliable, clinically ...
This easy-to-navigate reference provides clear, current, clinically proven recommendations for diagnosis and treatment of neurologic disorders....
... enable all those involved with healthcare decisions ... very latest evidence in their field of ... each year as the volume of evidence ... delivering the best single source available for ...
Treatment Strategies in Cardiovascular Medicine...
Medicine Products: